quinoxalines has been researched along with Metabolic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, L; Lecomte, F; Manevski, N; Pitt, WR; Toselli, F | 1 |
| Cordeiro, MN; Fernandes, R; Noronha, JP; Pereira, JA; Pessoa, AM; Prudêncio, C; Vieira, M | 1 |
| Dupont, P; Gillet, C; Guerin, M; Guillaumin, C; Kalamarides, S; Larinier, E; Meignan, C; Moreau, A; Perriot, J | 1 |
2 review(s) available for quinoxalines and Metabolic Diseases
| Article | Year |
|---|---|
Metabolism by Aldehyde Oxidase: Drug Design and Complementary Approaches to Challenges in Drug Discovery.
Topics: Aldehyde Oxidase; Animals; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Metabolic Diseases; Pharmaceutical Preparations | 2019 |
Quinoxaline, its derivatives and applications: A State of the Art review.
Topics: Animals; Chronic Disease; Drug Discovery; Humans; Metabolic Diseases; Quinoxalines | 2015 |
1 other study(ies) available for quinoxalines and Metabolic Diseases
| Article | Year |
|---|---|
[Tolerability profile of varenicline in current medical practice].
Topics: Adult; Benzazepines; Female; France; Gastrointestinal Diseases; Humans; Male; Mental Disorders; Metabolic Diseases; Nervous System Diseases; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Skin Diseases; Smoking; Varenicline | 2010 |